Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity	NANOGP8 NANOG	1.49e-05	4	32	2	GO:0001010
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	MYT1L TCF3 NANOGP8 SIM1 TFAP2D GMEB2 RFX1 EGR1 NANOG	2.73e-04	1412	32	9	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	MYT1L TCF3 NANOGP8 SIM1 TFAP2D GMEB2 RFX1 EGR1 NANOG	3.48e-04	1459	32	9	GO:0000977
GeneOntologyMolecularFunction	lysine-acetylated histone binding	NANOGP8 NANOG	1.05e-03	30	32	2	GO:0070577
GeneOntologyMolecularFunction	acetylation-dependent protein binding	NANOGP8 NANOG	1.12e-03	31	32	2	GO:0140033
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity, RNA polymerase II-specific	MYT1L TCF3 NANOGP8 NANOG	1.63e-03	320	32	4	GO:0001227
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity	MYT1L TCF3 NANOGP8 NANOG	1.75e-03	326	32	4	GO:0001217
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	MYT1L TCF3 NANOGP8 EGR1 NANOG	1.83e-03	560	32	5	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	MYT1L TCF3 NANOGP8 EGR1 NANOG	1.92e-03	566	32	5	GO:0001216
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	MYT1L TCF3 NANOGP8 GMEB2 RFX1 EGR1 NANOG	3.04e-03	1244	32	7	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	MYT1L TCF3 NANOGP8 GMEB2 RFX1 EGR1 NANOG	3.43e-03	1271	32	7	GO:0000987
GeneOntologyBiologicalProcess	negative regulation of endodermal cell fate specification	NANOGP8 NANOG	1.40e-05	4	32	2	GO:0042664
GeneOntologyBiologicalProcess	regulation of endodermal cell fate specification	NANOGP8 NANOG	2.33e-05	5	32	2	GO:0042663
GeneOntologyBiologicalProcess	negative regulation of endodermal cell differentiation	NANOGP8 NANOG	3.48e-05	6	32	2	GO:1903225
GeneOntologyBiologicalProcess	negative regulation of cell fate specification	NANOGP8 NANOG	6.49e-05	8	32	2	GO:0009996
GeneOntologyBiologicalProcess	regulation of endodermal cell differentiation	NANOGP8 NANOG	1.04e-04	10	32	2	GO:1903224
GeneOntologyBiologicalProcess	endodermal cell fate specification	NANOGP8 NANOG	1.27e-04	11	32	2	GO:0001714
GeneOntologyBiologicalProcess	cell dedifferentiation	NANOGP8 NANOG	2.42e-04	15	32	2	GO:0043697
GeneOntologyBiologicalProcess	dedifferentiation	NANOGP8 NANOG	2.42e-04	15	32	2	GO:0043696
GeneOntologyBiologicalProcess	negative regulation of cell fate commitment	NANOGP8 NANOG	3.13e-04	17	32	2	GO:0010454
GeneOntologyBiologicalProcess	endodermal cell fate commitment	NANOGP8 NANOG	3.51e-04	18	32	2	GO:0001711
GeneOntologyBiologicalProcess	regulation of stem cell division	NANOGP8 NANOG	3.51e-04	18	32	2	GO:2000035
GeneOntologyBiologicalProcess	mesodermal cell fate commitment	NANOGP8 NANOG	5.78e-04	23	32	2	GO:0001710
GeneOntologyCellularComponent	chromatin	MYT1L TCF3 NANOGP8 SIM1 TFAP2D GMEB2 RFX1 EGR1 NANOG	2.75e-04	1480	32	9	GO:0000785
Domain	PAM2	ATXN2L USP10	1.02e-04	9	32	2	PF07145
Domain	Ataxin-2_C	ATXN2L USP10	1.02e-04	9	32	2	IPR009818
Domain	GPS	CELSR2 ADGRG4	1.54e-03	34	32	2	SM00303
Domain	GPS	CELSR2 ADGRG4	1.63e-03	35	32	2	PF01825
Domain	GPS	CELSR2 ADGRG4	1.73e-03	36	32	2	PS50221
Domain	GPS	CELSR2 ADGRG4	1.82e-03	37	32	2	IPR000203
Domain	G_PROTEIN_RECEP_F2_1	CELSR2 ADGRG4	2.13e-03	40	32	2	PS00649
Domain	G_PROTEIN_RECEP_F2_3	CELSR2 ADGRG4	2.13e-03	40	32	2	PS50227
Domain	GPCR_2_extracellular_dom	CELSR2 ADGRG4	2.13e-03	40	32	2	IPR001879
Domain	G_PROTEIN_RECEP_F2_2	CELSR2 ADGRG4	3.31e-03	50	32	2	PS00650
Domain	7tm_2	CELSR2 ADGRG4	3.31e-03	50	32	2	PF00002
Domain	GPCR_2-like	CELSR2 ADGRG4	4.73e-03	60	32	2	IPR017981
Domain	GPCR_2_secretin-like	CELSR2 ADGRG4	4.73e-03	60	32	2	IPR000832
Domain	G_PROTEIN_RECEP_F2_4	CELSR2 ADGRG4	4.89e-03	61	32	2	PS50261
Domain	USP_CS	USP10 USP4	5.70e-03	66	32	2	IPR018200
Domain	USP_1	USP10 USP4	6.39e-03	70	32	2	PS00972
Domain	UCH	USP10 USP4	6.57e-03	71	32	2	PF00443
Domain	USP_2	USP10 USP4	6.57e-03	71	32	2	PS00973
Domain	USP_3	USP10 USP4	6.75e-03	72	32	2	PS50235
Domain	USP_dom	USP10 USP4	6.75e-03	72	32	2	IPR028889
Domain	Peptidase_C19_UCH	USP10 USP4	6.75e-03	72	32	2	IPR001394
Domain	-	CELSR2 ADGRG4	1.15e-02	95	32	2	2.60.120.200
Pathway	WP_ALSTROM_SYNDROME	CEP192 ALMS1 RFX1	3.21e-05	34	26	3	M45524
Pubmed	Mitochondrial respiration controls the Prox1-Vegfr3 feedback loop during lymphatic endothelial cell fate specification and maintenance.	LYVE1 EGR1 CD34	2.56e-07	14	32	3	33931446
Pubmed	Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species.	NANOGP8 NANOG	8.20e-07	2	32	2	24598770
Pubmed	Differential expression of nanog1 and nanogp8 in colon cancer cells.	NANOGP8 NANOG	8.20e-07	2	32	2	22079639
Pubmed	Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells.	NANOGP8 NANOG	8.20e-07	2	32	2	21136380
Pubmed	Functional evidence that the self-renewal gene NANOG regulates human tumor development.	NANOGP8 NANOG	8.20e-07	2	32	2	19415763
Pubmed	NANOG-dependent function of TET1 and TET2 in establishment of pluripotency.	NANOGP8 NANOG EMSY	2.04e-06	27	32	3	23395962
Pubmed	Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	25825768
Pubmed	Epithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation.	NANOGP8 NANOG	2.46e-06	3	32	2	31891567
Pubmed	Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4.	NANOGP8 NANOG	2.46e-06	3	32	2	19447925
Pubmed	The pluripotency factor NANOG controls primitive hematopoiesis and directly regulates Tal1.	NANOGP8 NANOG	2.46e-06	3	32	2	30814124
Pubmed	Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog.	NANOGP8 NANOG	2.46e-06	3	32	2	14728807
Pubmed	Isolation and characterization of the murine Nanog gene promoter.	NANOGP8 NANOG	2.46e-06	3	32	2	15916719
Pubmed	The molecular logic of Nanog-induced self-renewal in mouse embryonic stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	30846691
Pubmed	Generation of germline-competent induced pluripotent stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	17554338
Pubmed	Multiple phases in regulation of Nanog expression during pre-implantation development.	NANOGP8 NANOG	2.46e-06	3	32	2	26660234
Pubmed	Nanog retrotransposed genes with functionally conserved open reading frames.	NANOGP8 NANOG	2.46e-06	3	32	2	16845474
Pubmed	Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions.	NANOGP8 NANOG	2.46e-06	3	32	2	21194951
Pubmed	Identification and regulation of a stage-specific stem cell niche enriched by Nanog-positive spermatogonial stem cells in the mouse testis.	NANOGP8 NANOG	2.46e-06	3	32	2	22388986
Pubmed	NANOG changes in mouse kidneys with age.	NANOGP8 NANOG	2.46e-06	3	32	2	16313224
Pubmed	Crystal structure and DNA binding of the homeodomain of the stem cell transcription factor Nanog.	NANOGP8 NANOG	2.46e-06	3	32	2	18177668
Pubmed	Nanog promotes transfer of pluripotency after cell fusion.	NANOGP8 NANOG	2.46e-06	3	32	2	16791199
Pubmed	Expression of Nanog gene promotes NIH3T3 cell proliferation.	NANOGP8 NANOG	2.46e-06	3	32	2	16259959
Pubmed	Effect of Nanog overexpression on the metastatic potential of a mouse melanoma cell line B16-BL6.	NANOGP8 NANOG	2.46e-06	3	32	2	33665763
Pubmed	A novel NK-type homeobox gene, ENK (early embryo specific NK), preferentially expressed in embryonic stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	12609610
Pubmed	Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	18024963
Pubmed	The pluripotency factor Nanog regulates pericentromeric heterochromatin organization in mouse embryonic stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	27125671
Pubmed	Cutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-β1.	NANOGP8 NANOG	2.46e-06	3	32	2	24227785
Pubmed	Reprogramming capacity of Nanog is functionally conserved in vertebrates and resides in a unique homeodomain.	NANOGP8 NANOG	2.46e-06	3	32	2	22028025
Pubmed	Context-Dependent Functions of NANOG Phosphorylation in Pluripotency and Reprogramming.	NANOGP8 NANOG	2.46e-06	3	32	2	28457890
Pubmed	Requirement of Nanog dimerization for stem cell self-renewal and pluripotency.	NANOGP8 NANOG	2.46e-06	3	32	2	18436640
Pubmed	Stochastic promoter activation affects Nanog expression variability in mouse embryonic stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	25410303
Pubmed	Nanog co-regulated by Nodal/Smad2 and Oct4 is required for pluripotency in developing mouse epiblast.	NANOGP8 NANOG	2.46e-06	3	32	2	24929238
Pubmed	Nanog and transcriptional networks in embryonic stem cell pluripotency.	NANOGP8 NANOG	2.46e-06	3	32	2	17211451
Pubmed	The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis.	NANOGP8 NANOG	2.46e-06	3	32	2	23770853
Pubmed	The stem cell pluripotency factor NANOG activates transcription with two unusually potent subdomains at its C terminus.	NANOGP8 NANOG	2.46e-06	3	32	2	15502159
Pubmed	Genome editing demonstrates that the -5 kb Nanog enhancer regulates Nanog expression by modulating RNAPII initiation and/or recruitment.	NANOGP8 NANOG	2.46e-06	3	32	2	33334884
Pubmed	NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation.	NANOGP8 NANOG	2.46e-06	3	32	2	21499299
Pubmed	Nanog variability and pluripotency regulation of embryonic stem cells--insights from a mathematical model analysis.	NANOGP8 NANOG	2.46e-06	3	32	2	20574542
Pubmed	lincRNAs act in the circuitry controlling pluripotency and differentiation.	NANOGP8 NANOG	2.46e-06	3	32	2	21874018
Pubmed	Cell signalling regulates dynamics of Nanog distribution in embryonic stem cell populations.	NANOGP8 NANOG	2.46e-06	3	32	2	23054952
Pubmed	Phosphorylation of NANOG by casein kinase I regulates embryonic stem cell self-renewal.	NANOGP8 NANOG	2.46e-06	3	32	2	33107035
Pubmed	Nanog-independent reprogramming to iPSCs with canonical factors.	NANOGP8 NANOG	2.46e-06	3	32	2	24527385
Pubmed	Aromatic residues in the C-terminal domain 2 are required for Nanog to mediate LIF-independent self-renewal of mouse embryonic stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	18086680
Pubmed	Forced expression of Nanog in hematopoietic stem cells results in a gammadeltaT-cell disorder.	NANOGP8 NANOG	2.46e-06	3	32	2	17360937
Pubmed	H3K9 tri-methylation at Nanog times differentiation commitment and enables the acquisition of primitive endoderm fate.	NANOGP8 NANOG	2.46e-06	3	32	2	35976266
Pubmed	Nanog dynamics in single embryonic stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	26760119
Pubmed	Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	17204467
Pubmed	CrxOS maintains the self-renewal capacity of murine embryonic stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	19800316
Pubmed	Nanog is dispensable for the generation of induced pluripotent stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	24461999
Pubmed	Chromatin decondensation and nuclear softening accompany Nanog downregulation in embryonic stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	23200040
Pubmed	Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog.	NANOGP8 NANOG	2.46e-06	3	32	2	26975336
Pubmed	Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3.	NANOGP8 NANOG	2.46e-06	3	32	2	23329853
Pubmed	Locating and Characterizing a Transgene Integration Site by Nanopore Sequencing.	NANOGP8 NANOG	2.46e-06	3	32	2	30837263
Pubmed	NANOG alone induces germ cells in primed epiblast in vitro by activation of enhancers.	NANOGP8 NANOG	2.46e-06	3	32	2	26751055
Pubmed	Nanog induces hyperplasia without initiating tumors.	NANOGP8 NANOG	2.46e-06	3	32	2	25173648
Pubmed	Distinct Contributions of Tryptophan Residues within the Dimerization Domain to Nanog Function.	NANOGP8 NANOG	2.46e-06	3	32	2	27939294
Pubmed	Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	17352742
Pubmed	OCT4/SOX2-independent Nanog autorepression modulates heterogeneous Nanog gene expression in mouse ES cells.	NANOGP8 NANOG	2.46e-06	3	32	2	23178592
Pubmed	Stochastic NANOG fluctuations allow mouse embryonic stem cells to explore pluripotency.	NANOGP8 NANOG	2.46e-06	3	32	2	25005472
Pubmed	Cell-permeant recombinant Nanog protein promotes pluripotency by inhibiting endodermal specification.	NANOGP8 NANOG	2.46e-06	3	32	2	24681518
Pubmed	Roles of the Nanog protein in murine F9 embryonal carcinoma cells and their endoderm-differentiated counterparts.	NANOGP8 NANOG	2.46e-06	3	32	2	16773043
Pubmed	Genome-wide chromatin interactions of the Nanog locus in pluripotency, differentiation, and reprogramming.	NANOGP8 NANOG	2.46e-06	3	32	2	23665121
Pubmed	Ectopic overexpression of Nanog induces tumorigenesis in non-tumorous fibroblasts.	NANOGP8 NANOG	2.46e-06	3	32	2	26733157
Pubmed	Transient Activation of Mitoflashes Modulates Nanog at the Early Phase of Somatic Cell Reprogramming.	NANOGP8 NANOG	2.46e-06	3	32	2	26549484
Pubmed	mNanog possesses dorsal mesoderm-inducing ability by modulating both BMP and Activin/nodal signaling in Xenopus ectodermal cells.	NANOGP8 NANOG	2.46e-06	3	32	2	23071603
Pubmed	Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features.	NANOGP8 NANOG	2.46e-06	3	32	2	16501172
Pubmed	Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	19582141
Pubmed	Identification of genes regulated by nanog which is involved in ES cells pluripotency and early differentiation.	NANOGP8 NANOG	2.46e-06	3	32	2	18442017
Pubmed	NANOG induction of fetal liver kinase-1 (FLK1) transcription regulates endothelial cell proliferation and angiogenesis.	NANOGP8 NANOG	2.46e-06	3	32	2	21119109
Pubmed	Pluripotency factor NANOG promotes germ cell maintenance in vitro without triggering dedifferentiation of spermatogonial stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	32145514
Pubmed	Nanog is the gateway to the pluripotent ground state.	NANOGP8 NANOG	2.46e-06	3	32	2	19703398
Pubmed	Nanog safeguards pluripotency and mediates germline development.	NANOGP8 NANOG	2.46e-06	3	32	2	18097409
Pubmed	Nanog Fluctuations in Embryonic Stem Cells Highlight the Problem of Measurement in Cell Biology.	NANOGP8 NANOG	2.46e-06	3	32	2	28636920
Pubmed	Heterogeneities in Nanog Expression Drive Stable Commitment to Pluripotency in the Mouse Blastocyst.	NANOGP8 NANOG	2.46e-06	3	32	2	25753417
Pubmed	A distinct expression pattern in mammalian testes indicates a conserved role for NANOG in spermatogenesis.	NANOGP8 NANOG	2.46e-06	3	32	2	20539761
Pubmed	Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes.	NANOGP8 NANOG	2.46e-06	3	32	2	18584034
Pubmed	Alternative splicing produces Nanog protein variants with different capacities for self-renewal and pluripotency in embryonic stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	21969378
Pubmed	The phosphoinositide-3-kinase/Akt pathway mediates the transient increase in Nanog expression during differentiation of F9 cells.	NANOGP8 NANOG	2.46e-06	3	32	2	20661723
Pubmed	NANOG restores the impaired myogenic differentiation potential of skeletal myoblasts after multiple population doublings.	NANOGP8 NANOG	2.46e-06	3	32	2	29245050
Pubmed	Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype.	NANOGP8 NANOG	2.46e-06	3	32	2	22337995
Pubmed	Mapping dynamic histone acetylation patterns to gene expression in nanog-depleted murine embryonic stem cells.	NANOGP8 NANOG	2.46e-06	3	32	2	21187909
Pubmed	Functional analysis of two Sp1/Sp3 binding sites in murine Nanog gene promoter.	NANOGP8 NANOG	2.46e-06	3	32	2	16541131
Pubmed	Role of Nanog in the maintenance of marrow stromal stem cells during post natal bone regeneration.	NANOGP8 NANOG	2.46e-06	3	32	2	22142851
Pubmed	The pluripotency rheostat Nanog functions as a dimer.	NANOGP8 NANOG	2.46e-06	3	32	2	18290762
Pubmed	NANOG amplifies STAT3 activation and they synergistically induce the naive pluripotent program.	NANOGP8 NANOG	2.46e-06	3	32	2	24462001
Pubmed	Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.	NANOGP8 NANOG	2.46e-06	3	32	2	23333380
Pubmed	A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal.	NANOGP8 NANOG	2.46e-06	3	32	2	16790525
Pubmed	Primitive endoderm differentiates via a three-step mechanism involving Nanog and RTK signaling.	NANOGP8 NANOG	2.46e-06	3	32	2	22172669
Pubmed	Nanog-dependent feedback loops regulate murine embryonic stem cell heterogeneity.	NANOGP8 NANOG	2.46e-06	3	32	2	23103910
Pubmed	Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation.	NANOGP8 NANOG	2.46e-06	3	32	2	15494369
Pubmed	Expression dynamics of Mage family genes during self-renewal and differentiation of mouse pluripotent stem and teratocarcinoma cells.	NANOGP8 MAGEE1 NANOG	3.79e-06	33	32	3	31143371
Pubmed	The histone acetyltransferase Myst2 regulates Nanog expression, and is involved in maintaining pluripotency and self-renewal of embryonic stem cells.	NANOGP8 NANOG	4.92e-06	4	32	2	25743411
Pubmed	CtBP-interacting BTB zinc finger protein (CIBZ) promotes proliferation and G1/S transition in embryonic stem cells via Nanog.	NANOGP8 NANOG	4.92e-06	4	32	2	22315219
Pubmed	GATA-1 directly regulates Nanog in mouse embryonic stem cells.	NANOGP8 NANOG	4.92e-06	4	32	2	26296469
Pubmed	Expansion of undifferentiated murine embryonic stem cells as aggregates in suspension culture bioreactors.	NANOGP8 NANOG	4.92e-06	4	32	2	17518637
Pubmed	Cyclic mechanical strain maintains Nanog expression through PI3K/Akt signaling in mouse embryonic stem cells.	NANOGP8 NANOG	4.92e-06	4	32	2	22683858
Pubmed	USP21 deubiquitylates Nanog to regulate protein stability and stem cell pluripotency.	NANOGP8 NANOG	4.92e-06	4	32	2	29263902
Pubmed	Nanog positively regulates Zfp57 expression in mouse embryonic stem cells.	NANOGP8 NANOG	4.92e-06	4	32	2	25445595
Pubmed	Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog.	NANOGP8 NANOG	4.92e-06	4	32	2	19171902
Pubmed	Low-Level Nanog Expression in the Regulation of Quiescent Endothelium.	NANOGP8 NANOG	4.92e-06	4	32	2	32640900
GeneFamily	Ubiquitin specific peptidases	USP10 USP4	1.91e-03	56	21	2	366
GeneFamily	NKL subclass homeoboxes and pseudogenes	NANOGP8 NANOG	2.71e-03	67	21	2	519
GeneFamily	Basic helix-loop-helix proteins	TCF3 SIM1	7.14e-03	110	21	2	420
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	CEP192 MAP1B	1.85e-02	181	21	2	694
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	VIT MAP1B EGR1 ADGRG4	1.03e-05	191	32	4	2c51850f5c559d665b8a27a12b75af9ed58dffe1
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYT1L MAGEE1 NRG3 MAP1B	1.10e-05	194	32	4	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-tip_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	LYVE1 MAP1B SHROOM2 CD34	1.21e-05	199	32	4	1c69395c9305b6ecb0a826d46c8e8ec95795ad6d
ToppCell	Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	VIT MAP1B CD34 LRRTM2	1.24e-05	200	32	4	29054cf55e88e1ac81a562d8dd9af9b7c749321d
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|kidney / Disease (COVID-19 only), tissue and cell type	MYT1L GRM3 ADGRG4	1.34e-04	139	32	3	64c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	MYT1L COX7A2L MAP1B	1.61e-04	148	32	3	a1269312903fc27830c1835dabf660c659a711be
ToppCell	normal_Lymph_Node-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	LYVE1 CELSR2 EGR1	1.78e-04	153	32	3	5424494ea1f09542799045a875cc3eac13de5079
ToppCell	PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_C\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	LYVE1 CD34 CLASRP	1.88e-04	156	32	3	6c8f442ed94ae31e6832b68137e98ae78091ac6c
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cbln4_Fezf2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GRM3 EGR1 CD34	2.03e-04	160	32	3	d8241404d775f9a709abdf17988f36293fcf4c58
ToppCell	droplet-Heart-nan-24m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF3 VIT EGR1	2.07e-04	161	32	3	eb546d5065ac506405d240f9a1f55f2122d0c368
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LYVE1 VIT MAP1B	2.14e-04	163	32	3	8f24cef152f5965727bbeee116bd26c75cbba82a
ToppCell	3'_v3-Lung-Lymphocytic_B-ABC_aged-B_memory\|Lung / Manually curated celltypes from each tissue	TCF3 MAP1B EGR1	2.18e-04	164	32	3	7766900740f67dbbe3c4d90fbfdcc1665cee6515
ToppCell	Endothelial-B-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	LYVE1 MAP1B CD34	2.22e-04	165	32	3	b6893882472aeb0d18e26f47eaec9d53688afcde
ToppCell	severe-HSPC\|World / disease stage, cell group and cell class	CD34 SPESP1 LRRTM2	2.38e-04	169	32	3	b0421b73bfdc92f7a2762b4b670b9eae124aa702
ToppCell	severe_COVID-19-Neutrophil\|World / disease group, cell group and cell class (v2)	USP10 LYVE1 EGR1	2.43e-04	170	32	3	dfc807e0dd66179490a258ecbe8eb439e715799d
ToppCell	Endothelial-B-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	LYVE1 MAP1B CD34	2.51e-04	172	32	3	d4e98ff9c7cbc95457e1d71fa60f151a2f178dae
ToppCell	Endothelial-B-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	LYVE1 MAP1B CD34	2.51e-04	172	32	3	8a527dff06d841a86c7eb04a1dd9630787294da4
ToppCell	PND01-03-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	LYVE1 TCF3 CD34	2.60e-04	174	32	3	cb0109661e8c9ca04d67d33f2d926f0e649bf67d
ToppCell	Thalamus-Neuronal-Excitatory\|Thalamus / BrainAtlas - Mouse McCarroll V32	MYT1L NRG3 MAP1B	2.69e-04	176	32	3	d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66
ToppCell	Control-Neuronal_cells\|Control / group, cell type (main and fine annotations)	LYVE1 NRG3 MAP1B	2.69e-04	176	32	3	c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCell	normal_Lung-Endothelial_cells-EPCs\|normal_Lung / Location, Cell class and cell subclass	LYVE1 NRG3 CD34	2.69e-04	176	32	3	71d1bd425772d89d8c550b909e0ec0e36ff22a7e
ToppCell	Control-Neuronal_cells-Neuronal_cells\|Control / group, cell type (main and fine annotations)	LYVE1 NRG3 MAP1B	2.69e-04	176	32	3	98c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell	356C-Endothelial_cells-Endothelial-D\|356C / Donor, Lineage, Cell class and subclass (all cells)	LYVE1 CD34 LRRTM2	2.73e-04	177	32	3	a0b172f40e0df97a288a5549ae7066697ad469b3
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LYVE1 CELSR2 CD34	2.73e-04	177	32	3	0e74980a7686c31fcf1476b8f19a3392541df240
ToppCell	356C-Endothelial_cells-Endothelial-D-\|356C / Donor, Lineage, Cell class and subclass (all cells)	LYVE1 CD34 LRRTM2	2.73e-04	177	32	3	ab8f09e118e4df696b0b4d33f013da020bdbd351
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SIM1 EGR1 ADGRG4	2.82e-04	179	32	3	f2e8fc975c30992611630197b79daaeef7c4211d
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYT1L LYVE1 CD34	2.87e-04	180	32	3	b35a8c6169f4b548b912af005e92ae7c6596f376
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	LYVE1 SHROOM2 CD34	2.96e-04	182	32	3	fec1caf867b1dc87b24504d895ee1a27df78062e
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	VIT MAP1B EGR1	2.96e-04	182	32	3	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LYVE1 NKTR MAP1B	3.01e-04	183	32	3	4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D122\|Adult / Lineage, Cell type, age group and donor	VIT MAP1B CD34	3.06e-04	184	32	3	2b7e6f91e11c228f0521e099886867d9e998e78d
ToppCell	droplet-Mammary_Gland-nan-18m-Mesenchymal-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRM3 EGR1 CD34	3.06e-04	184	32	3	fe4d3def3da4ffdea5ae6bb059f5397efd58fef3
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	VIT MAP1B EGR1	3.11e-04	185	32	3	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	Endothelial-B-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	LYVE1 MAP1B CD34	3.11e-04	185	32	3	133c9dc64d564dae4aeeeca22f386aa3f13fa980
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATXN2L CELSR2 EGR1	3.16e-04	186	32	3	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	droplet-Fat-SCAT-30m-Epithelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR2 MAP1B SHROOM2	3.21e-04	187	32	3	5fada3c5a58c1890029ccbfff2608b33f8cd2df7
ToppCell	droplet-Fat-SCAT-30m-Epithelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR2 MAP1B SHROOM2	3.21e-04	187	32	3	766e808138fc2cd623c2e6d57fcb5c7378da0e03
ToppCell	droplet-Fat-SCAT-30m-Epithelial-epithelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CELSR2 MAP1B SHROOM2	3.21e-04	187	32	3	f49d06600060deeb2fc1b1da5b93496535f20104
ToppCell	Cerebellum-Neuronal\|Cerebellum / BrainAtlas - Mouse McCarroll V32	MYT1L NRG3 MAP1B	3.21e-04	187	32	3	61b9d6eb131a674598aa8409d7fa909c8765442d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1L CELSR2 MAP1B	3.21e-04	187	32	3	e04a84989d624378141042768383b9c846901f2d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1L CELSR2 MAP1B	3.21e-04	187	32	3	24cc03c748e15f7ef0e6509ca5a6ca583fb9c573
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYT1L CELSR2 MAP1B	3.21e-04	187	32	3	2f153b203fe79f206319603cf94d3a03ab49a05d
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-endo_bronchial_(8)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.26e-04	188	32	3	986aaf31161ec3d1e6c76ee2dd17f44848a21f7e
ToppCell	Endothelial-endothelial_cell_of_lymph_vessel\|World / Lineage, Cell type, age group and donor	LYVE1 NRG3 MAP1B	3.26e-04	188	32	3	80910dcbb51990f2baed240f319456c0d3fa2065
ToppCell	Endothelial-B\|World / lung cells shred on cell class, cell subclass, sample id	LYVE1 MAP1B CD34	3.26e-04	188	32	3	5959a88728812a5f4cbfa54eddc7a73ccbaa2f68
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LYVE1 NRG3 MAP1B	3.26e-04	188	32	3	c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MYT1L MAP1B ADGRG4	3.31e-04	189	32	3	8e6b6025f5554672e26a5d19fe365acb4333789c
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LYVE1 NRG3 MAP1B	3.31e-04	189	32	3	0d18ea72bd58d32a8ab9a61cf97f5786642f804b
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VIT ADGRG4 CD34	3.31e-04	189	32	3	d531399749409d614adca13d181830c6e3287508
ToppCell	facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_progenitor\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VIT EGR1 CD34	3.36e-04	190	32	3	dc7e92f1b18d0f5efec11d09d56ba954d4f8b3bd
ToppCell	facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VIT EGR1 CD34	3.36e-04	190	32	3	0bb06df3d5a50416854370f234718c6cec3d773b
ToppCell	facs-SCAT-Fat-24m-Mesenchymal\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VIT EGR1 CD34	3.36e-04	190	32	3	008290bb5c79446681dd6bf354336c57ad0d6f13
ToppCell	IPF-Endothelial-Lymphatic\|World / Disease state, Lineage and Cell class	LYVE1 NRG3 MAP1B	3.36e-04	190	32	3	ac029e73da5995221c9b9af551d85e4b835e21d6
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	LYVE1 SHROOM2 CD34	3.41e-04	191	32	3	44c596984c6196f6014e0e405dbe5560841e54ff
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKTR MAP1B EGR1	3.41e-04	191	32	3	7d1595e616f6f111fc2f5bc1b179c5d67d624cc9
ToppCell	E16.5-samps-Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	LYVE1 SHROOM2 CD34	3.41e-04	191	32	3	e7521d4d24f016d4e531cd492a7a69604f0c9e6f
ToppCell	Control-Endothelial-Lymphatic\|World / Disease state, Lineage and Cell class	LYVE1 NRG3 MAP1B	3.46e-04	192	32	3	f95fb188aa642f3d0618242a770e7c4b70544adb
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	VIT ADGRG4 CD34	3.46e-04	192	32	3	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	droplet-Pancreas-Endocrine\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKTR MAP1B EGR1	3.46e-04	192	32	3	0dfd1e9896c34aee0f842f8de5d0e3af62a15f68
ToppCell	Entopeduncular-Neuronal\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	MYT1L NRG3 MAP1B	3.46e-04	192	32	3	4c35e5c28a40b439044797ba1f06cb7c36b2a8de
ToppCell	15-Trachea-Endothelial-Endothelial\|Trachea / Age, Tissue, Lineage and Cell class	LYVE1 NRG3 CD34	3.52e-04	193	32	3	6ea0444fc3dc156997129387184e6418947f4b12
ToppCell	LAM-Endothelial-LymEndo\|LAM / Condition, Lineage and Cell class	LYVE1 MAP1B CD34	3.52e-04	193	32	3	68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9
ToppCell	Posterior_cortex-Neuronal\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	MYT1L NRG3 MAP1B	3.52e-04	193	32	3	b4989e3436e84dbec3789b46057e0f7a0ebf09d4
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature4_(5)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.52e-04	193	32	3	01c71aa48875b5ad6c50cc810a72862e72f26ad0
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-endo_venous_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.52e-04	193	32	3	84d1c1b7d3a1cb80f175527e3c89a2c3da7657f7
ToppCell	15-Trachea-Endothelial\|Trachea / Age, Tissue, Lineage and Cell class	LYVE1 NRG3 CD34	3.52e-04	193	32	3	b1ebf8df2d55e2938e5a495ea68b80c4ac216dc0
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	NRG3 SHROOM2 EGR1	3.57e-04	194	32	3	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature4_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.57e-04	194	32	3	53a5e8863d79a052dff0758f389be5ac3883c721
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKTR MAP1B EGR1	3.57e-04	194	32	3	0b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell	PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_venous_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.62e-04	195	32	3	ca2cf2c10db1ad17aa0a2e30aa7079a7ad751ea6
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LYVE1 MAP1B CD34	3.62e-04	195	32	3	8f3b455553215f6e191842a5953a79c606f22c08
ToppCell	Mesenchymal_cells-Stromal_fibro.\|World / Lineage and Cell class	VIT EGR1 CD34	3.62e-04	195	32	3	69723b06c2a5c2aaf4d10874b11bca7f06822bdc
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LYVE1 MAP1B CD34	3.62e-04	195	32	3	0ff59b073b88fab1f6ed98508714cab430c7d079
ToppCell	COVID-19-Heart-Low_count_Fib\|COVID-19 / Disease (COVID-19 only), tissue and cell type	VIT EGR1 CD34	3.62e-04	195	32	3	e09590d1f51d5fa57fceb84c9f48f84b23d4d224
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VIT ADGRG4 CD34	3.62e-04	195	32	3	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LYVE1 MAP1B CD34	3.62e-04	195	32	3	7e71b1707b34ce47fffadf6f64d9554768221fc6
ToppCell	wk_15-18-Endothelial-Blood_vessel_endothelial-Venous_endo\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.62e-04	195	32	3	cc3d6f98d310e8840ff497d7258c5ccf54e6c624
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LYVE1 MAP1B CD34	3.62e-04	195	32	3	3ea2b5ecb66faddeefffbf0d39fc7cb5abf35ad7
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NKTR MAP1B EGR1	3.62e-04	195	32	3	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	Fibroblasts-CD34+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	MAP1B EGR1 CD34	3.62e-04	195	32	3	c6b5249ac8714b1b701cde31d00ab53f28355c36
ToppCell	3'-GW_trimst-2-LargeIntestine\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1B EGR1 CD34	3.68e-04	196	32	3	27a216af92100224818c91e298428bee25ab0af8
ToppCell	PCW_13-14-Endothelial\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.68e-04	196	32	3	7286de29a34e13834cd6347c67a1443897fa4ade
ToppCell	PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating1_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.68e-04	196	32	3	b826dce5b3daa8eb3d4a530b9564de58d9ce3767
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MYT1L NRG3 MAP1B	3.68e-04	196	32	3	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.68e-04	196	32	3	29ed8b1c4cd730db8632fde6eece404f1883a86d
ToppCell	PCW_10-12-Endothelial-Endothelial_immature\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.68e-04	196	32	3	c65b8c7ea34a21897c390e6fb42ee8ca41e9c976
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature_venous_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.68e-04	196	32	3	81278e696d823744267d6315c4d42799c4ea0b2c
ToppCell	PCW_13-14-Endothelial-Endothelial_immature\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.68e-04	196	32	3	9ed96085f0acce07bf2f8d4cc212cc50e613be0c
ToppCell	PCW_10-12-Endothelial\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.68e-04	196	32	3	2c60dcf9132ee156f25b349e2ac5313709def4f6
ToppCell	PCW_05-06-Endothelial-Endothelial_immature-endo_immature_venous_(4)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.68e-04	196	32	3	85b697db1c925eff8bbef9d74565c82be5a0ddcc
ToppCell	proximal-Endothelial-Capillary-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LYVE1 CD34 CLASRP	3.73e-04	197	32	3	ddb8ea895f0f34d4f20a0740b708fa0f3e378801
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature3_(11)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.73e-04	197	32	3	a7922f65a8af4a773e4ce80114e4d895a594fa2f
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.73e-04	197	32	3	4e9221cb02122aed2981c3c9157e847a3710e323
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature3_(11)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	LYVE1 NRG3 CD34	3.73e-04	197	32	3	21a1080e1db3a64f3eccc7aed2b3189332d31038
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VIT MAP1B CD34	3.73e-04	197	32	3	17344464fdcc5ba0c03959696b97c195f11e644c
ToppCell	proximal-Endothelial-Capillary\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LYVE1 CD34 CLASRP	3.73e-04	197	32	3	53baef54bd85c60ae24a3c163b3a3d937fb6ff0b
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	VIT ADGRG4 CD34	3.73e-04	197	32	3	c747c496ac090309b7f8a3e9d840928f12c83f2f
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	VIT MAP1B CD34	3.73e-04	197	32	3	3bb92dd8a94e2be3b7fe51c9a21b241215477ac7
ToppCell	facs-Heart-RA-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VIT MAP1B EGR1	3.73e-04	197	32	3	940cf1e54d7c820e04946258a8b784f35c6a144c
ToppCell	proximal-3-Endothelial-Capillary\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LYVE1 CD34 CLASRP	3.73e-04	197	32	3	a1a61c03d67272693ec23e0d15f0a12bf618e2da
Disease	colon cancer (implicated_via_orthology)	NANOGP8 NANOG	5.46e-05	11	30	2	DOID:219 (implicated_via_orthology)
Disease	neuroticism measurement, cognitive function measurement	ATXN2L COX7A2L USP4 SIM1 GRM3	2.44e-04	566	30	5	EFO_0007660, EFO_0008354
Disease	caudate nucleus volume	MYT1L ATXN2L	4.27e-04	30	30	2	EFO_0004830
Disease	diet measurement	MYT1L NANOGP8 VIT TFAP2D NRG3 CELSR2	5.68e-04	1049	30	6	EFO_0008111
Disease	Malignant neoplasm of breast	SIM1 MAGEE1 TFAP2D SHROOM2 EMSY CLASRP	6.43e-04	1074	30	6	C0006142
Disease	refractive error, age at onset, Myopia	TFAP2D GRM3 CD34	9.82e-04	193	30	3	EFO_0004847, HP_0000545, MONDO_0004892
Disease	Obesity	MYT1L SIM1 INPP5E	1.17e-03	205	30	3	C0028754
Disease	obesity (implicated_via_orthology)	TCF3 SIM1 ALMS1	1.34e-03	215	30	3	DOID:9970 (implicated_via_orthology)
Disease	alcohol consumption measurement	MYT1L ATXN2L COX7A2L TFAP2D ALMS1 GRM3	1.37e-03	1242	30	6	EFO_0007878
Disease	factor VII activating protease measurement	USP10 NRG3	1.44e-03	55	30	2	EFO_0009368
Disease	body weight	MYT1L ATXN2L CEP192 SIM1 TFAP2D EGR1	1.48e-03	1261	30	6	EFO_0004338
Disease	irritability measurement	USP4 SIM1	3.16e-03	82	30	2	EFO_0009594
Disease	visual epilepsy (biomarker_via_orthology)	MAP1B EGR1	3.79e-03	90	30	2	DOID:11832 (biomarker_via_orthology)
Disease	sleep duration, low density lipoprotein cholesterol measurement	CELSR2 CLASRP	3.87e-03	91	30	2	EFO_0004611, EFO_0005271
Disease	low density lipoprotein cholesterol measurement, alcohol consumption measurement	SIM1 CELSR2	4.56e-03	99	30	2	EFO_0004611, EFO_0007878
Disease	hip circumference	ATXN2L TFAP2D NRG3	4.81e-03	338	30	3	EFO_0005093
Disease	low density lipoprotein cholesterol measurement, alcohol drinking	SIM1 CELSR2	4.83e-03	102	30	2	EFO_0004329, EFO_0004611
Disease	grip strength measurement	ATXN2L TFAP2D GRM3	5.30e-03	350	30	3	EFO_0006941
Disease	attention deficit hyperactivity disorder	MYT1L TFAP2D MAP1B	5.47e-03	354	30	3	EFO_0003888

Protein segments in the cluster

Peptide	Gene	Start	Entry
YTTISYSNTTSPPLE	ADGRG4	281	Q8IZF6
TTYSQSSASTYVPTV	GRM3	851	Q14832
KTETPSVSSSLYSYR	ALMS1	1701	Q8TCU4
TKSTLTSSYNCPSPY	CELSR2	2636	Q9HCU4
VKTTYDSSLSSYTVP	ATXN2L	266	Q8WWM7
STVAYSSSSPLTYST	TFAP2D	36	Q7Z6R9
YTVLASSGSTYPSTV	GMEB2	431	Q9UKD1
PETSTSPKFHTTTYS	NRG3	266	P56975
DPTTEYTKRISSSSY	LRRTM2	376	O43300
RTTKSPSDSGYSYET	MAP1B	1911	P46821
EGYSYETSTKTTRTP	MAP1B	2021	P46821
DSTYSVASPYSTIPA	LYVE1	166	Q9Y5Y7
VPSPDSEVSSYSSKY	MAGEE1	721	Q9HCI5
DTYDSTSKQRTPSYT	INPP5E	541	Q9NRR6
TSSLSSYPSPVATSY	EGR1	436	P18146
TQKASAPTYPSLYSS	NANOG	166	Q9H9S0
TPTKLTSDSTVYDYA	COX7A2L	41	O14548
TYVSEPESSYPTTAT	CEP192	1041	Q8TEP8
VVCYSYTSTTSTPTS	EMSY	141	Q7Z589
TSLATSPTKPYTSSS	CD34	151	P28906
STYSKYSDRSSESSP	NKTR	676	P30414
SYPETPLYTQTASTS	RFX1	316	P22670
TQKASAPTYPSLYSS	NANOGP8	166	Q6NSW7
SSSKSKSRTSPYPQY	SIM1	376	P81133
SLATNSTYYSTSAPK	SHROOM2	1391	Q13796
TESSTSPYVTSYKSP	SPESP1	166	Q6UW49
TYDPYKRSPSESSSE	CLASRP	296	Q8N2M8
FTTSPKSSASPYSSV	USP4	241	Q13107
DATAYPSAKTPSSTY	TCF3	196	P15923
YPSALTYSSSKSPAA	VIT	146	Q6UXI7
SQSTSYLPGYVPKTS	MRPL21	41	Q7Z2W9
PSSSSPVAYVETKYS	USP10	351	Q14694
YCKDPSPSSSSTSSY	MYT1L	681	Q9UL68